Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wellgistics Health (WGRX) EPS (Weighted Average and Diluted) (2024 - 2025)

Wellgistics Health filings provide 2 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.25 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 150.0% to -$0.25 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.92, a 534.05% decrease, with the full-year FY2025 number at -$1.43, down 853.33% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.25 in Q4 2025 for Wellgistics Health, up from -$0.46 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q1 2024 to a low of -$0.62 in Q1 2025.